Fate Therapeutics (F6T) Q2 2024 Earnings Report
DE:F6T Q2 2024 EPS Results
- Actual EPS
- -EUR 0.30
- Consensus EPS
- -EUR 0.42
- Beat/Miss
- Beat by +EUR 0.12
- One Year Ago EPS
- -EUR 0.48
DE:F6T Q2 2024 Revenue Results
- Actual Revenue
- EUR 6.06M
- Expected Revenue
- EUR 1.19M
- Beat/Miss
- Beat by +EUR 4.88M
- YoY Revenue Growth
- +625.83%
Earnings Announcement Details
- Quarter
- Q2 2024
- Date
- 08/13/2024
- Time
- After Close
- Conference Call
- Tuesday, August 13, 2024
DE:F6T Upcoming Earnings
Fate Therapeutics's next earnings date is estimated for March 1, 2027, based on past reporting schedules.
Q2 2024 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2024 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:F6T Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 01, 2027 | 2026 (Q4) | ―- | -0.24 | ― | ― |
| Oct 29, 2026 | 2026 (Q3) | -0.24- | -0.24 | ― | |
| Aug 13, 2026 | 2026 (Q2) | -0.24-0.22 | -0.26 | 13.79% (+0.04) | |
| May 13, 2026 | 2026 (Q1) | -0.25-0.23 | -0.29 | 18.75% (+0.05) | |
| Feb 26, 2026 | 2025 (Q4) | -0.24-0.24 | -0.39 | 38.64% (+0.15) | |
| Nov 13, 2025 | 2025 (Q3) | -0.26-0.24 | -0.36 | 32.50% (+0.12) | |
| Aug 12, 2025 | 2025 (Q2) | -0.31-0.26 | -0.3 | 12.12% (+0.04) | |
| May 13, 2025 | 2025 (Q1) | -0.34-0.29 | -0.42 | 31.91% (+0.13) | |
| Mar 05, 2025 | 2024 (Q4) | -0.39-0.39 | -0.4 | 2.22% (+0.01) | |
| Nov 12, 2024 | 2024 (Q3) | -0.37-0.36 | -0.41 | 13.04% (+0.05) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
